David A. Fox

17.5k total citations · 4 hit papers
230 papers, 13.4k citations indexed

About

David A. Fox is a scholar working on Immunology, Rheumatology and Molecular Biology. According to data from OpenAlex, David A. Fox has authored 230 papers receiving a total of 13.4k indexed citations (citations by other indexed papers that have themselves been cited), including 124 papers in Immunology, 59 papers in Rheumatology and 47 papers in Molecular Biology. Recurrent topics in David A. Fox's work include T-cell and B-cell Immunology (67 papers), Immunotherapy and Immune Responses (40 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). David A. Fox is often cited by papers focused on T-cell and B-cell Immunology (67 papers), Immunotherapy and Immune Responses (40 papers) and Monoclonal and Polyclonal Antibodies Research (39 papers). David A. Fox collaborates with scholars based in United States, United Kingdom and Japan. David A. Fox's co-authors include Steven K. Lundy, Sujata Sarkar, Laura Tesmer, Ellis L. Reinherz, Stuart F. Schlossman, Judith Endres, Rebecca E. Hussey, Alison M. Gizinski, Oreste Acuto and David H. Katz and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

David A. Fox

223 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NETs Are a Source of Citrullinated Autoantigens and Stimulate Inflammatory Responses in Rheumatoid Arthritis

2013 1.0k citations Carmelo Carmona‐Rivera, Paul R. Thompson et al. profile →
An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein

1984 1.0k citations David A. Fox et al. profile →
Th17 cells in human disease

2008 898 citations Sujata Sarkar, David A. Fox et al. profile →
Efficacy of Low-Dose Methotrexate in Rheumatoid Arthritis

1985 705 citations David A. Fox et al. profile →

Peers

Countries citing papers authored by David A. Fox

Since Specialization

Citations

This map shows the geographic impact of David A. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Fox more than expected).

Fields of papers citing papers by David A. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Fox. The network helps show where David A. Fox may publish in the future.

Co-authorship network of co-authors of David A. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Fox. A scholar is included among the top collaborators of David A. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Fox. David A. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CD6 in Human Disease 2025 ·Cells ·(unknown), David A. Fox, Javier S. Castresana	0
2	Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cells 2024 ·Cancer Immunology Immunotherapy ·(unknown), Qi Wu, M. Asif Amin, Pei‐Suen Tsou, Phillip L. Campbell, (unknown), (unknown), (unknown), (unknown), Sei Muraoka, (unknown), (unknown), Jeffrey H. Ruth, Yang Mao‐Draayer, Shengli Ding, Xiling Shen, Laura A. Cooney, Feng Lin, David A. Fox	6
3	230 Immunosuppression causes dynamic changes in expression QTLs in psoriatic skin 2023 ·Journal of Investigative Dermatology ·Laura A. Cooney, Qian Xiao, Jason A. Mears, (unknown), (unknown), Yuriy Baglaenko, Noha Lim, Kristina M. Harris, Mark S. Anderson, David A. Fox, Dawn E. Smilek, James G. Krueger, Soumya Raychaudhuri	1
4	Reporting and Establishment of Reference Intervals for Antiphospholipid Antibody Immunoassays: A Survey of Participants in the College of American Pathologists Proficiency Testing Program 2023 ·Archives of Pathology & Laboratory Medicine ·Anne E. Tebo, (unknown), (unknown), (unknown), David A. Fox, Michael A. Linden, William Karlon	3
5	Real-World Treatment Patterns of Older Adults with Locally Advanced SCCHN Using SEER-Medicare 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Shumin Zhou, Chi‐Fai Ng, (unknown), (unknown), (unknown), Sujith Baliga, David A. Fox	1
6	CD6-targeted antibody-drug conjugate as a new therapeutic agent for T cell lymphoma 2023 ·Leukemia ·Neetha Parameswaran, (unknown), Lingjun Zhang, (unknown), Frank P. DiFilippo, (unknown), David A. Fox, Sarah L. Ondrejka, Eric D. Hsi, Deepa Jagadeesh, Daniel J. Lindner, Feng Lin	8
7	Inhibition of bromodomain extraterminal histone readers alleviates skin fibrosis in experimental models of scleroderma 2022 ·JCI Insight ·(unknown), (unknown), M. Asif Amin, Phillip L. Campbell, Qi Wu, (unknown), (unknown), (unknown), (unknown), Sei Muraoka, Jeffrey H. Ruth, (unknown), (unknown), (unknown), Yang Mao‐Draayer, David A. Fox, Dinesh Khanna, Amr H. Sawalha, Pei‐Suen Tsou	12
8	CD6 is a target for cancer immunotherapy 2021 ·JCI Insight ·Jeffrey H. Ruth, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Asif Amin, Phillip L. Campbell, Pei‐Suen Tsou, Yang Mao‐Draayer, Qi Wu, Thomas M. Lanigan, Venkateshwar G. Keshamouni, Nora G. Singer, Feng Lin, David A. Fox	34
9	Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis 2020 ·Science Advances ·Liam J. O’Neil, Ana Barrera‐Vargas, (unknown), Javier Merayo‐Chalico, (unknown), Angel Aponte, (unknown), Marjan Guček, Hani El‐Gabalawy, David A. Fox, James D. Katz, Mariana J. Kaplan, Carmelo Carmona‐Rivera	81
10	Absence of complement component 3 does not prevent classical pathway–mediated hemolysis 2019 ·Blood Advances ·Lingjun Zhang, (unknown), Ping Huang, Thomas L. Saunders, David A. Fox, Jijun Xu, Feng Lin	10
11	Synovial fibroblast-neutrophil interactions promote pathogenic adaptive immunity in rheumatoid arthritis 2017 ·Science Immunology ·Carmelo Carmona‐Rivera, Philip M. Carlucci, Erica Moore, Nithya Lingampalli, Hannes Uchtenhagen, Eddie A. James, Yudong Liu, Kevin L. Bicker, Heidi Wähämaa, Victoria Hoffmann, Anca I. Catrina, Paul R. Thompson, Jane H. Buckner, William H. Robinson, David A. Fox, Mariana J. Kaplan	239
12	Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics 2014 ·Arthritis Research & Therapy ·Glynn Dennis, Cécile Holweg, Sarah Kummerfeld, David F. Choy, Audi Setiadi, Jason A. Hackney, Peter M. Haverty, Houston Gilbert, Wei Lin, Lauri Diehl, Sven Fischer, (unknown), David Musselman, Micki Klearman, Cem Gabay, Arthur Kavanaugh, Judith Endres, David A. Fox, Flavius Martin, Michael J. Townsend	265
13	Membrane-Type I Matrix Metalloproteinase-Dependent Regulation of Rheumatoid Arthritis Synoviocyte Function 2010 ·The Journal of Immunology ·Farideh Sabeh, David A. Fox, Stephen J. Weiss	86
14	A medication therapy management program's impact on low-density lipoprotein cholesterol goal attainment in Medicare Part D patients with diabetes 2009 ·Journal of the American Pharmacists Association ·David A. Fox, L. Douglas Ried, (unknown), (unknown), (unknown)	41
15	Interactions of T Cells with Fibroblast-Like Synoviocytes: Role of the B7 Family Costimulatory Ligand B7-H3 2008 ·The Journal of Immunology ·Chinh Tran, Seth G. Thacker, (unknown), (unknown), Peter White, Judith Endres, Andrew G. Urquhart, Kevin C. Chung, David A. Fox	57
16	Expression and Characterization of a Novel CD6 Ligand in Cells Derived from Joint and Epithelial Tissues 2004 ·The Journal of Immunology ·(unknown), David A. Fox, Sujata Sarkar, S. M. A. Abidi, Judith Endres, (unknown), Tariq M. Haqqi, Nora G. Singer	31
17	Effector Function of Resting T Cells: Activation of Synovial Fibroblasts 2001 ·The Journal of Immunology ·(unknown), Raj Gupta, Yoshitaka Morita, Xiaogang He, (unknown), Judith Endres, Andrew A. Freiberg, Kevin C. Chung, David A. Fox	90
18	A Method for Monoclonal Antibody Isotype Switching: Anti-CD60 V _H Expression in a Heavy Chain-Deficient Hybridoma Variant 1995 ·Hybridoma ·Karen Kozarsky, (unknown), J. Schaller, Mark Kaminski, J L Claflin, David A. Fox	2
19	A novel pathway of human T lymphocyte activation. Identification by a monoclonal antibody generated against a rheumatoid synovial T cell line. 1988 ·The Journal of Immunology ·(unknown), (unknown), Karen Kozarsky, (unknown), Kan Li, (unknown), (unknown), William C. Davis, David A. Fox	55
20	Clinical Genetics Society. Abstracts of scientific papers presented on 18 and 19 September 1980 in Aberdeen 1981 ·Journal of Medical Genetics ·E. Boyd, Ruth Sanger, M.J.W. Faed, (unknown), Janet Robertson, David A. Fox, Michael C. W. Yip, (unknown), (unknown), Mark Roberts	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact